Annual EPS
-$3.50
+$1.01+22.39%
December 31, 2023
Summary
- As of February 8, 2025, CLRB annual earnings per share is -$3.50, with the most recent change of +$1.01 (+22.39%) on December 31, 2023.
- During the last 3 years, CLRB annual EPS has risen by +$4.10 (+53.95%).
- CLRB annual EPS is now at all-time high.
Performance
CLRB EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.40
-$0.22-122.22%
September 30, 2024
Summary
- As of February 8, 2025, CLRB quarterly earnings per share is -$0.40, with the most recent change of -$0.22 (-122.22%) on September 30, 2024.
- Over the past year, CLRB quarterly EPS has increased by +$0.01 (+2.44%).
- CLRB quarterly EPS is now -100.00% below its all-time high of $161.84 thousand, reached on March 31, 2010.
Performance
CLRB Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$1.90
+$1.15+37.70%
September 30, 2024
Summary
- As of February 8, 2025, CLRB TTM earnings per share is -$1.90, with the most recent change of +$1.15 (+37.70%) on September 30, 2024.
- Over the past year, CLRB TTM EPS has increased by +$1.60 (+45.71%).
- CLRB TTM EPS is now -100.00% below its all-time high of $83.33 thousand, reached on December 31, 2010.
Performance
CLRB TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
CLRB EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.4% | +2.4% | +45.7% |
| 3 y3 years | +54.0% | +58.8% | +53.8% |
| 5 y5 years | +93.3% | +90.5% | +90.4% |
CLRB EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +22.4% | -122.2% | +74.2% | at high | +57.9% |
| 5 y | 5-year | at high | +81.0% | -122.2% | +90.5% | at high | +90.4% |
| alltime | all time | at high | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
Cellectar Biosciences EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.40(+122.2%) | -$1.90(-37.7%) |
| Jun 2024 | - | -$0.18(-80.2%) | -$3.05(-19.1%) |
| Mar 2024 | - | -$0.91(+122.0%) | -$3.77(+7.7%) |
| Dec 2023 | -$3.50(-22.4%) | -$0.41(-73.5%) | -$3.50(-14.6%) |
| Sep 2023 | - | -$1.55(+72.2%) | -$4.10(+7.0%) |
| Jun 2023 | - | -$0.90(+40.6%) | -$3.83(-7.7%) |
| Mar 2023 | - | -$0.64(-36.6%) | -$4.15(-8.0%) |
| Dec 2022 | -$4.51(+3.7%) | -$1.01(-21.1%) | -$4.51(+1.1%) |
| Sep 2022 | - | -$1.28(+4.9%) | -$4.46(+7.5%) |
| Jun 2022 | - | -$1.22(+22.0%) | -$4.15(+2.0%) |
| Mar 2022 | - | -$1.00(+4.2%) | -$4.07(-6.9%) |
| Dec 2021 | -$4.35(-42.8%) | -$0.96(-1.0%) | -$4.37(+6.3%) |
| Sep 2021 | - | -$0.97(-14.9%) | -$4.11(-11.4%) |
| Jun 2021 | - | -$1.14(-12.3%) | -$4.64(-23.9%) |
| Mar 2021 | - | -$1.30(+85.7%) | -$6.10(-32.2%) |
| Dec 2020 | -$7.60(-58.7%) | -$0.70(-53.3%) | -$9.00(-22.4%) |
| Sep 2020 | - | -$1.50(-42.3%) | -$11.60(-18.9%) |
| Jun 2020 | - | -$2.60(-38.1%) | -$14.30(-12.3%) |
| Mar 2020 | - | -$4.20(+27.3%) | -$16.30(-17.3%) |
| Dec 2019 | -$18.40(-64.8%) | -$3.30(-21.4%) | -$19.70(-19.6%) |
| Sep 2019 | - | -$4.20(-8.7%) | -$24.49(-33.4%) |
| Jun 2019 | - | -$4.60(-39.5%) | -$36.79(-25.1%) |
| Mar 2019 | - | -$7.60(-6.0%) | -$49.09(-21.1%) |
| Dec 2018 | -$52.30(-51.1%) | -$8.09(-51.0%) | -$62.19(-29.4%) |
| Sep 2018 | - | -$16.50(-2.4%) | -$88.10(-9.5%) |
| Jun 2018 | - | -$16.90(-18.4%) | -$97.40(-6.1%) |
| Mar 2018 | - | -$20.70(-39.1%) | -$103.70(-3.1%) |
| Dec 2017 | -$107.00(-50.0%) | -$34.00(+31.8%) | -$107.00(-16.8%) |
| Sep 2017 | - | -$25.80(+11.2%) | -$128.60(-11.8%) |
| Jun 2017 | - | -$23.20(-3.3%) | -$145.80(-15.0%) |
| Mar 2017 | - | -$24.00(-56.8%) | -$171.60(+203.2%) |
| Dec 2016 | -$214.00(-69.6%) | -$55.60(+29.3%) | -$56.60(-138.0%) |
| Sep 2016 | - | -$43.00(-12.2%) | $149.00(-375.9%) |
| Jun 2016 | - | -$49.00(-153.8%) | -$54.00(-82.4%) |
| Mar 2016 | - | $91.00(-39.3%) | -$307.00(-56.3%) |
| Dec 2015 | -$703.00 | $150.00(-161.0%) | -$702.00(-45.8%) |
| Sep 2015 | - | -$246.00(-18.5%) | -$1294.59(+31.0%) |
| Jun 2015 | - | -$302.00(-0.7%) | -$988.59(-30.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | -$304.00(-31.3%) | -$1416.59(-33.9%) |
| Dec 2014 | -$1753.00(-54.6%) | -$442.59(-837.7%) | -$2142.59(-30.7%) |
| Sep 2014 | - | $60.00(-108.2%) | -$3090.00(-14.4%) |
| Jun 2014 | - | -$730.00(-29.1%) | -$3610.00(+0.3%) |
| Mar 2014 | - | -$1030.00(-25.9%) | -$3600.00(-9.3%) |
| Dec 2013 | -$3860.00(-16.1%) | -$1390.00(+202.2%) | -$3970.00(+10.9%) |
| Sep 2013 | - | -$460.00(-36.1%) | -$3580.00(-17.1%) |
| Jun 2013 | - | -$720.00(-48.6%) | -$4320.00(-10.0%) |
| Mar 2013 | - | -$1400.00(+40.0%) | -$4800.00(+4.3%) |
| Dec 2012 | -$4600.00(-25.8%) | -$1000.00(-16.7%) | -$4600.00(-4.2%) |
| Sep 2012 | - | -$1200.00(0.0%) | -$4800.00(-4.0%) |
| Jun 2012 | - | -$1200.00(0.0%) | -$5000.00(-13.8%) |
| Mar 2012 | - | -$1200.00(0.0%) | -$5800.00(-47.9%) |
| Dec 2011 | -$6200.00(-80.0%) | -$1200.00(-14.3%) | -$11.12 K(-14.9%) |
| Sep 2011 | - | -$1400.00(-30.0%) | -$13.06 K(-58.0%) |
| Jun 2011 | - | -$2000.00(-69.3%) | -$31.11 K(-63.4%) |
| Mar 2011 | - | -$6521.97(+107.6%) | -$85.04 K(-202.1%) |
| Dec 2010 | -$31.02 K(-97.4%) | -$3141.77(-83.8%) | $83.33 K(-115.6%) |
| Sep 2010 | - | -$19.45 K(-65.2%) | -$534.48 K(-25.2%) |
| Jun 2010 | - | -$55.92 K(-134.6%) | -$714.25 K(-33.1%) |
| Mar 2010 | - | $161.84 K(-126.1%) | -$1.07 M(-27.1%) |
| Dec 2009 | -$1.19 M(-27.2%) | -$620.95 K(+211.7%) | -$1.47 M(+40.6%) |
| Sep 2009 | - | -$199.22 K(-51.4%) | -$1.04 M(-1.9%) |
| Jun 2009 | - | -$410.08 K(+74.2%) | -$1.06 M(-27.0%) |
| Mar 2009 | - | -$235.40 K(+19.1%) | -$1.45 M(-21.1%) |
| Dec 2008 | -$1.64 M(-33.8%) | -$197.67 K(-9.7%) | -$1.84 M(-17.1%) |
| Sep 2008 | - | -$218.94 K(-72.7%) | -$2.22 M(-13.6%) |
| Jun 2008 | - | -$802.04 K(+28.3%) | -$2.57 M(-11.2%) |
| Mar 2008 | - | -$625.32 K(+8.1%) | -$2.90 M(+17.0%) |
| Dec 2007 | -$2.48 M(+247.7%) | -$578.48 K(+1.8%) | -$2.48 M(+16.5%) |
| Sep 2007 | - | -$568.13 K(-49.6%) | -$2.13 M(+18.3%) |
| Jun 2007 | - | -$1.13 M(+452.3%) | -$1.80 M(+125.2%) |
| Mar 2007 | - | -$203.91 K(-10.6%) | -$798.00 K(+12.0%) |
| Dec 2006 | -$712.26 K(+179.9%) | -$228.18 K(-4.5%) | -$712.26 K(+31.2%) |
| Sep 2006 | - | -$238.91 K(+88.1%) | -$542.82 K(+78.6%) |
| Jun 2006 | - | -$126.99 K(+7.5%) | -$303.91 K(+71.8%) |
| Mar 2006 | - | -$118.17 K(+101.2%) | -$176.91 K(+90.3%) |
| Dec 2005 | -$254.45 K | -$58.74 K(+71.6%) | -$92.97 K(+171.6%) |
| Mar 2005 | - | -$34.23 K | -$34.23 K |
FAQ
- What is Cellectar Biosciences annual earnings per share?
- What is the all time high annual EPS for Cellectar Biosciences?
- What is Cellectar Biosciences annual EPS year-on-year change?
- What is Cellectar Biosciences quarterly earnings per share?
- What is the all time high quarterly EPS for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly EPS year-on-year change?
- What is Cellectar Biosciences TTM earnings per share?
- What is the all time high TTM EPS for Cellectar Biosciences?
- What is Cellectar Biosciences TTM EPS year-on-year change?
What is Cellectar Biosciences annual earnings per share?
The current annual EPS of CLRB is -$3.50
What is the all time high annual EPS for Cellectar Biosciences?
Cellectar Biosciences all-time high annual earnings per share is -$3.50
What is Cellectar Biosciences annual EPS year-on-year change?
Over the past year, CLRB annual earnings per share has changed by +$1.01 (+22.39%)
What is Cellectar Biosciences quarterly earnings per share?
The current quarterly EPS of CLRB is -$0.40
What is the all time high quarterly EPS for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly earnings per share is $161.84 K
What is Cellectar Biosciences quarterly EPS year-on-year change?
Over the past year, CLRB quarterly earnings per share has changed by +$0.01 (+2.44%)
What is Cellectar Biosciences TTM earnings per share?
The current TTM EPS of CLRB is -$1.90
What is the all time high TTM EPS for Cellectar Biosciences?
Cellectar Biosciences all-time high TTM earnings per share is $83.33 K
What is Cellectar Biosciences TTM EPS year-on-year change?
Over the past year, CLRB TTM earnings per share has changed by +$1.60 (+45.71%)